Safety of Human Recombinant Proteins

Biomedical and Environmental Sciences

Volumn 10, Issue 1, 1997, Pages 65-71

  Ryffel, Bernhard ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR; ERYTHROPOIETIN; INTERFERON; INTERLEUKIN DERIVATIVE; RECOMBINANT PROTEIN; THROMBOPOIETIN;

ANIMAL; BIOSYNTHESIS; DRUG DESIGN; DRUG EFFECT; GENE THERAPY; HEMATOPOIESIS; HUMAN; MOUSE; MOUSE MUTANT; PRACTICE GUIDELINE; PREDICTION AND FORECASTING; PRIMATE; RAT; REVIEW;

ANIMALS; COLONY-STIMULATING FACTORS; DRUG DESIGN; ERYTHROPOIETIN; GENE THERAPY; GUIDELINES; HEMATOPOIESIS; HUMANS; INTERFERONS; INTERLEUKINS; MICE; MICE, KNOCKOUT; PREDICTIVE VALUE OF TESTS; PRIMATES; RATS; RECOMBINANT PROTEINS; THROMBOPOIETIN;

EID: 0031088659     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Aggarwal, B. B. and Pocisik, E. (1992). Cytokines: From clone to clinic. Arch. Biochem. Biophys. 292, 335-359.
2. Aggarwal, B. B. and Puri, R. K. (1995). Human Cytokines: Their Role in Disease and Therapy. Blackwell Science Publ., Cambridge.
3. Arai, K, Lee, F., Miyajima, A., Miyatake, S., Arai, N., and Yokota, T. (1990). Cytokines of immune and inflammatory responses. Annu. Rev. Biochem. 59, 783-836.
4. Beutler, B. (1992). Tumor necrosis factors: The Molecules and Their Emerging Role in Medicine, PP1-590. Raven Press, NY.
5. Brunda, M. J. (1994). Interleukin-12. Review. J. Leukocyte Biol. 55, 280-296.
6. Car, B. D., Eng, V. M., Schnyder, B., Ozmen, L., Huang, S., Gallay, Ph., Heumann, D., Aguet, M., and Ryffel, B. (1994). INF-γ receptor deficient mice are resistant to endotoxic shock. J. Exp. Med. 179, 1437-1444.
7. Car, B. D., Eng, V. M., Schnyder, B, LeHir, M., Shakhov, A., and Ryffel, B. (1995). Role of interferon-γ in interleukin 12 induced pathology in mice. Am. J. Pathol. 147, 1693-1707.
8. Davies, J., and Rosenberg, M. (1994). Mammalian gene studies. Current Opinion Biotechology 5, 604-636.
9. Dexter, T. M., Garland, J. M., and Test, N. G. (1990). Colony Stimulating Factors. Marcel Dekker, New York.
10. Eugster, H. P., Müller M., and Ryffel, B. (1996). Multiple immunodeficiencies in TNF-LT double knockout mice. Int. Immunol. 8, 23-36.
11. Eng, V. M, Car B. D., Schnyder, B., Lorenz, M., Lugli, S., Aguet, M., Anderson, T. D., Ryffel, B, and Quesniaux, V. (1995). The stimulatory effect of IL-12 on hematopoiesis are inhibited by IL-12 IFNγ in vivo. J. Exp. Med. 181, 1893-1898.
12. Gately, M. K., Warrier, R. R., Honasoge, S., Carvajal, D. M., Faherty. D. A., Connaughton, S. E., Anderson, T. D., Sarmiento, U., Hubbard, B. R., and Murphy, M. (1993). Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo. Int Immunol. 6, 157-167.
13. Gianella-Borradori, A. (1992), Impact of hemopoietic growth factors in clinical oncology: Present and future. Triangle (Sandoz) 31, 35-43.
14. Grau, G. E., Lambert, P. H., Vassalli, P., and Piguet, P. F. (1993). Tumor necrosis factor/Cachectin as an effector of T cell-dependent immunopathology. In Int. Rev. Exp. Pathology, Vol. 34, Cytokine Induced Pathology, B, pp. 159-171. Academic Press, Inc.
15. Hirano, T., Akiro, S., Taga, T., and Kishimoto, T. (1990). Biological and clinical aspects of interleukin 6. Immunology Today 11, 443-449.
16. Huber, B. (1994). Gene therapy. Ann. NY Acad. Sci. 716, 1-366.
17. Klug, S. T., Neubert, R., Stahlmann, R., Thiel, R, Ryffel, B., Car B. D., and Neubert, D. (1994). Effects of recombinant human interleukin 6 (rhIL-6) in marmosets (Callithrix jacchus). Arch. Toxicol. 68, 619-631.
18. Moore, M. A. S. (1991). Hemopoetic growth factors. Ann. Rev. Immunol. 9, 159-191.
19. Robison, R. L., and Myers, L. A. (1993). Preclinical safety assessment of recombinant human GM-CSF in Rhesus Monkeys. In Int. Rev. Exp. Pathology, Vol. 34, Cytokine-induced Pathology, A, pp. 149-172. Academic Press, Inc.
20. Ryffel, B., Kammüller, M., Robison, R, and Myers, L. (1992). Pathology induced by interleukin-6. Toxicol. Letters 64/65, 311-319.
21. Ryffel, B. (1993a). Zytokine, Therapeutika, Toxine und Mediatoren der Toxizität. SWISSMED. 15, 16-20.
22. Ryffel, B. (1993b). Pathology induced by cytokines. Int. Rev. Exp. Pathology 34 p. 1-232. (A and B): A concise review on safety studies on a variety of cytokines, which are contributed by the experts in the specific area.
23. Ryffel, B., Car, B. D., Gunn, H., Roman, D., Hiestand, P., and Mihatsch, M. J. (1994a). Interleukin-6 exacerbates glomerulonephritis in (NZBxNZW F1) mice. Am. J. Pathol. 144, 927-937.
24. Ryffel, B., Car, B. D., Woerly, G., Weber, M., DiPadova, F., Kammüller, M., Klug, S., Neubert, R., Neubert, D. (1994b). Long-term interleukin-6 administration stimulates sustained and thrombopoiesis and acute phase protein synthesis in a small primate - the marmoset. Blood 83, 2093-2102.
25. Ryffel, B. (1995a). Interleukin-12: Adjuvans in der Tumortherapy? Therapiewoche Schweiz 11(5) 241-244.
26. Ryffel, B. (1995b). Use of knockout mice in pharmacological-toxicological research. Toxicology (in press).
27. Sarmiento, U. M., Riley, J. H., Knaack, P. A., Lipman, J. M., Becker, J. M., Gately, K., Chizzonite, R., and Anderson, T. D. (1994). Biologic effects of recombinant human interleukin-12 Squirrel Monkeys (Sciureus saimiri). Laboratory Investigation 71, 862-873.
28. Sundwall, A., Ekman; L., Johansson, H. E., Sjöberg, B., and Sjöhotm, I. (1990). Preclinical Evalt ation of Peptides and Recombinant Proteins. Skogs Grafiska AB Malmö, Workshop Stockholm Schw den May 7-8 1993.
29. Terrell, T. G., and Green, J. D. (1993). Comparative pathology of recombinant murine interferon-γ mice and recombinant human interferon-γ in cynomolgus monkeys. In Int. Rev. Exp. Pathology, 3 Cytokine-induced Pathology, B, pp. 73-101 Academic Press, Inc.
30. Trinchieri, G., and Scott, P. H. (1994). The role of interleukin 12 in the immunoresponse, disease an therapy. Immunology Today 15, 460-463.
31. Vassalli, P. (1992). The pathophysiology of tumor necrosis factor. Ann. Rev. Immunol. 10, 411-452
32. Woerly, G. and Ryffel, B. (1993). The use of receptor assays for the rapid selection of an appropriate an mal species for the preclinical investigations of human interleukins. In Vitro Toxicology 6, 67-79.
33. Zabner, J, Pertersen, D. M., Welsh, M. J. (1994). Safety and efficacy of repetitive adenovirus-mediate transfer of CFTR cDNA to airway epthelia of primates and cotton rats. Nature Genetics 6, 75-81.
34. Zbinden, G. (1990). Safety evaluation of biotechnology products. Drug Safety 5, 58-64.